LeMaitre Vascular Lowers Q4 GAAP EPS Guidance from $0.75-$0.81 to $0.70-$0.75 vs $0.78 Est; Lowers Q4 Sales Guidance from $71.100M-$73.100M to $69.900M-$71.900M vs $72.325M Est
Benzinga Newsdesk 1 day ago
NewsGuidance
LeMaitre Vascular (NASDAQ:LMAT) lowers Q4 GAAP EPS guidance from $0.75-$0.81 to $0.70-$0.75 vs $0.78 analyst estimate. Lowers Q4 sales outlook from $71.100 million-$73.100 million to $69.900 million-$71.900 million vs
LeMaitre Vascular (NASDAQ:LMAT) lowers Q4 GAAP EPS guidance from $0.75-$0.81 to $0.70-$0.75 vs $0.78 analyst estimate. Lowers Q4 sales outlook from $71.100 million-$73.100 million to $69.900 million-$71.900 million vs $72.325 million estimate.